Transitioning insulin pump therapy from the outpatient to the inpatient setting: A review of 6 years' experience with 253 cases

Curtiss B. Cook, Karen A. Beer, Karen M. Seifert, Mary E. Boyle, Patricia A. Mackey, Janna C. Castro

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: We reviewed the care of a large cohort of patients with diabetes mellitus on insulin pump therapy who required an inpatient stay. Methods: Records were reviewed of patients hospitalized between January 1, 2006, and December 31, 2011. Results: A total of 136 patients using insulin pumps had 253 hospitalizations. Mean (standard deviation) patient age was 55 (16) years, diabetes duration was 29 (15) years, and pump duration was 6 (5) years. Insulin pump therapy was continued in 164 (65%) hospitalizations. Adherence to core process measures improved over time: by 2011, 100% of cases had an endocrinology consultation, 100% had the required insulin pump order set completed, and 94% had documentation of the signed agreement specifying patient responsibilities for continued use of the technology while hospitalized. Documentation of the insulin pump flow sheet also increased but could still be located in only 64% of cases by the end of 2011. Mean glucose was not significantly diferent among patients who remained on insulin pump therapy compared to those for whom it was discontinued (p > .1), but episodes of severe hyperglycemia (>300 mg/dl) and hypoglycemia (<40 mg/dl) were significantly less common among pump users. No pump site infections, mechanical pump failures, or episodes of diabetic ketoacidosis were observed among patients remaining on therapy. Conclusions: With appropriate patient selection and usage guidelines, most patients using insulin pumps can safely have their therapy transitioned to the inpatient setting. Further study is needed to determine whether this approach can be translated to other hospital settings.

Original languageEnglish (US)
Pages (from-to)995-1002
Number of pages8
JournalJournal of diabetes science and technology
Volume6
Issue number5
DOIs
StatePublished - 2012

Fingerprint

Insulin
Inpatients
Outpatients
Pumps
Therapeutics
Documentation
Hospitalization
Medical problems
Diabetic Ketoacidosis
Endocrinology
Process Assessment (Health Care)
Hypoglycemia
Hyperglycemia
Patient Selection
Diabetes Mellitus
Referral and Consultation
Guidelines
Technology
Glucose
Infection

Keywords

  • Diabetes mellitus
  • Hospitalization
  • Inpatients
  • Insulin infusion systems

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Transitioning insulin pump therapy from the outpatient to the inpatient setting : A review of 6 years' experience with 253 cases. / Cook, Curtiss B.; Beer, Karen A.; Seifert, Karen M.; Boyle, Mary E.; Mackey, Patricia A.; Castro, Janna C.

In: Journal of diabetes science and technology, Vol. 6, No. 5, 2012, p. 995-1002.

Research output: Contribution to journalArticle

Cook, Curtiss B. ; Beer, Karen A. ; Seifert, Karen M. ; Boyle, Mary E. ; Mackey, Patricia A. ; Castro, Janna C. / Transitioning insulin pump therapy from the outpatient to the inpatient setting : A review of 6 years' experience with 253 cases. In: Journal of diabetes science and technology. 2012 ; Vol. 6, No. 5. pp. 995-1002.
@article{abdfac75eaaa4891b3a6ed59f7072029,
title = "Transitioning insulin pump therapy from the outpatient to the inpatient setting: A review of 6 years' experience with 253 cases",
abstract = "Background: We reviewed the care of a large cohort of patients with diabetes mellitus on insulin pump therapy who required an inpatient stay. Methods: Records were reviewed of patients hospitalized between January 1, 2006, and December 31, 2011. Results: A total of 136 patients using insulin pumps had 253 hospitalizations. Mean (standard deviation) patient age was 55 (16) years, diabetes duration was 29 (15) years, and pump duration was 6 (5) years. Insulin pump therapy was continued in 164 (65{\%}) hospitalizations. Adherence to core process measures improved over time: by 2011, 100{\%} of cases had an endocrinology consultation, 100{\%} had the required insulin pump order set completed, and 94{\%} had documentation of the signed agreement specifying patient responsibilities for continued use of the technology while hospitalized. Documentation of the insulin pump flow sheet also increased but could still be located in only 64{\%} of cases by the end of 2011. Mean glucose was not significantly diferent among patients who remained on insulin pump therapy compared to those for whom it was discontinued (p > .1), but episodes of severe hyperglycemia (>300 mg/dl) and hypoglycemia (<40 mg/dl) were significantly less common among pump users. No pump site infections, mechanical pump failures, or episodes of diabetic ketoacidosis were observed among patients remaining on therapy. Conclusions: With appropriate patient selection and usage guidelines, most patients using insulin pumps can safely have their therapy transitioned to the inpatient setting. Further study is needed to determine whether this approach can be translated to other hospital settings.",
keywords = "Diabetes mellitus, Hospitalization, Inpatients, Insulin infusion systems",
author = "Cook, {Curtiss B.} and Beer, {Karen A.} and Seifert, {Karen M.} and Boyle, {Mary E.} and Mackey, {Patricia A.} and Castro, {Janna C.}",
year = "2012",
doi = "10.1177/193229681200600502",
language = "English (US)",
volume = "6",
pages = "995--1002",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "5",

}

TY - JOUR

T1 - Transitioning insulin pump therapy from the outpatient to the inpatient setting

T2 - A review of 6 years' experience with 253 cases

AU - Cook, Curtiss B.

AU - Beer, Karen A.

AU - Seifert, Karen M.

AU - Boyle, Mary E.

AU - Mackey, Patricia A.

AU - Castro, Janna C.

PY - 2012

Y1 - 2012

N2 - Background: We reviewed the care of a large cohort of patients with diabetes mellitus on insulin pump therapy who required an inpatient stay. Methods: Records were reviewed of patients hospitalized between January 1, 2006, and December 31, 2011. Results: A total of 136 patients using insulin pumps had 253 hospitalizations. Mean (standard deviation) patient age was 55 (16) years, diabetes duration was 29 (15) years, and pump duration was 6 (5) years. Insulin pump therapy was continued in 164 (65%) hospitalizations. Adherence to core process measures improved over time: by 2011, 100% of cases had an endocrinology consultation, 100% had the required insulin pump order set completed, and 94% had documentation of the signed agreement specifying patient responsibilities for continued use of the technology while hospitalized. Documentation of the insulin pump flow sheet also increased but could still be located in only 64% of cases by the end of 2011. Mean glucose was not significantly diferent among patients who remained on insulin pump therapy compared to those for whom it was discontinued (p > .1), but episodes of severe hyperglycemia (>300 mg/dl) and hypoglycemia (<40 mg/dl) were significantly less common among pump users. No pump site infections, mechanical pump failures, or episodes of diabetic ketoacidosis were observed among patients remaining on therapy. Conclusions: With appropriate patient selection and usage guidelines, most patients using insulin pumps can safely have their therapy transitioned to the inpatient setting. Further study is needed to determine whether this approach can be translated to other hospital settings.

AB - Background: We reviewed the care of a large cohort of patients with diabetes mellitus on insulin pump therapy who required an inpatient stay. Methods: Records were reviewed of patients hospitalized between January 1, 2006, and December 31, 2011. Results: A total of 136 patients using insulin pumps had 253 hospitalizations. Mean (standard deviation) patient age was 55 (16) years, diabetes duration was 29 (15) years, and pump duration was 6 (5) years. Insulin pump therapy was continued in 164 (65%) hospitalizations. Adherence to core process measures improved over time: by 2011, 100% of cases had an endocrinology consultation, 100% had the required insulin pump order set completed, and 94% had documentation of the signed agreement specifying patient responsibilities for continued use of the technology while hospitalized. Documentation of the insulin pump flow sheet also increased but could still be located in only 64% of cases by the end of 2011. Mean glucose was not significantly diferent among patients who remained on insulin pump therapy compared to those for whom it was discontinued (p > .1), but episodes of severe hyperglycemia (>300 mg/dl) and hypoglycemia (<40 mg/dl) were significantly less common among pump users. No pump site infections, mechanical pump failures, or episodes of diabetic ketoacidosis were observed among patients remaining on therapy. Conclusions: With appropriate patient selection and usage guidelines, most patients using insulin pumps can safely have their therapy transitioned to the inpatient setting. Further study is needed to determine whether this approach can be translated to other hospital settings.

KW - Diabetes mellitus

KW - Hospitalization

KW - Inpatients

KW - Insulin infusion systems

UR - http://www.scopus.com/inward/record.url?scp=84875810987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875810987&partnerID=8YFLogxK

U2 - 10.1177/193229681200600502

DO - 10.1177/193229681200600502

M3 - Article

C2 - 23063024

AN - SCOPUS:84875810987

VL - 6

SP - 995

EP - 1002

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 5

ER -